{"cik":1818794,"taxonomy":"us-gaap","tag":"LongTermDebt","label":"Long-term Debt","description":"Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.","entityName":"Dyne Therapeutics, Inc.","units":{"USD":[{"end":"2024-12-31","val":0,"accn":"0000950170-25-099161","fy":2025,"fp":"Q2","form":"10-Q","filed":"2025-07-28"},{"end":"2024-12-31","val":0,"accn":"0001193125-25-266882","fy":2025,"fp":"Q3","form":"10-Q","filed":"2025-11-05"},{"end":"2024-12-31","val":0,"accn":"0001193125-26-084178","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-02","frame":"CY2024Q4I"},{"end":"2025-06-30","val":98813000,"accn":"0000950170-25-099161","fy":2025,"fp":"Q2","form":"10-Q","filed":"2025-07-28","frame":"CY2025Q2I"},{"end":"2025-09-30","val":99147000,"accn":"0001193125-25-266882","fy":2025,"fp":"Q3","form":"10-Q","filed":"2025-11-05","frame":"CY2025Q3I"},{"end":"2025-12-31","val":148921000,"accn":"0001193125-26-084178","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-02"},{"end":"2025-12-31","val":148921000,"accn":"0001193125-26-215702","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-11"},{"end":"2025-12-31","val":148921000,"accn":"0001193125-26-323639","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-07-29","frame":"CY2025Q4I"},{"end":"2026-03-31","val":149375000,"accn":"0001193125-26-215702","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-11","frame":"CY2026Q1I"},{"end":"2026-06-30","val":199328000,"accn":"0001193125-26-323639","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-07-29","frame":"CY2026Q2I"}]}}